Both Retatrutide and Wegovy represent significant advancements in diabetes care, but they function through distinct mechanisms. Semaglutide primarily affects GLP-1 receptors, promoting insulin release and https://sahilxjht854549.blogdosaga.com/41816474/novoretatrutide-vs-copyright-a-comparative-assessment